TrialBMC cardiovascular disorders2014

Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients.

Lise Pedersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.